Anti-Rhinovirus 16 [Clone R16-7] - 100 μg

Rhinoviruses (HRV), members of the Picornaviridae family, are ubiquitous and highly prevalent RNA viruses. These small, non-enveloped pathogens are characterized by their icosahedral capsid and a single-stranded, positive-sense RNA genome. The viral genome uniquely encodes a single polyprotein that is subsequently cleaved by viral proteases into essential structural and non-structural proteins, vital for viral replication and assembly. With over 100 known serotypes, Human Rhinoviruses are the primary cause of the common cold, leading to millions of upper airway infections annually. Beyond acute symptoms, HRV infections pose a significant health burden by exacerbating lower airway symptoms in vulnerable patient populations. They are well-documented triggers for severe complications in individuals suffering from asthma, cystic fibrosis (CF), and chronic obstructive pulmonary disease (COPD), often leading to increased hospitalizations and diminished quality of life. Our Anti-Rhinovirus 16 monoclonal antibody, Clone R16-7, is specifically developed to target Rhinovirus 16. This highly specific tool is indispensable for researchers investigating HRV pathogenesis, viral diagnostics, and the development of new antiviral therapies or vaccines. Leverage Clone R16-7 for precise detection and characterization of Rhinovirus 16 in your studies.